‘Xarelto’ registered for prioritized sales right as generic
The novel oral anticoagulant(NOAC), rivaroxaban(product name: Xarelto, Bayer)’ was registered in the list of pharmaceutical products with prioritized sales product approval for the 41th times.
SK Chemicals which succeeded in commercializing the first generic(first-developed generic drug) is abl...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
